AAO: Study backs recommendation against routine genetic testing for AMD

Certain gene variants may predict whether a person will develop age-related macular degeneration, but they do not predict how that person would respond to anti-VEGF therapy, a study found. The American Academy of Ophthalmology said this reinforces its recommendation against routine genetic testing for AMD. “The Academy advises against routine genetic testing for AMD and other complex eye disorders until specific treatment or monitoring strategies have been shown in clinical trials to be of benefit to people with specific, risk-linked genotypes,” the AAO said in a press release.

Full Story →